SCHEMBL6974981

SCHEMBL6974981

Cc1csc2ccc(C=O)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.55
ALDH1A1 P00352 6/20 0.38
ALDH1A3 P47895 2/20 0.38
TSHR P16473 1/20 0.36
KIF11 P52732 1/20 0.36
KDM4E B2RXH2 2/20 0.36
RAB9A P51151 2/20 0.36
PTGS2 P35354 2/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
PTK2B Q14289 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGER4 P35408 2/20 0.34
CHRNA7 P36544 1/20 0.34
HTR3A P46098 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16693081 0.85 CYP2A6 (0.42) CYP2A6ALDH1A1ALDH1A3TSHRKIF11
SCHEMBL14341667 0.81 CYP2A6 (0.55) CYP2A6ALDH1A1PTGS2MAPTPTGS1
SCHEMBL6976249 0.79 CYP2A6 (0.56) CYP2A6ALDH1A1ALDH1A3TSHRKIF11
SCHEMBL6973853 0.79 CYP2A6 (0.47) CYP2A6ALDH1A1TSHRKIF11KDM4E
SCHEMBL17669303 0.79 FFAR1 (0.46) CYP2A6KIF11PTGS2PTGS1
SCHEMBL16693175 0.79 CYP2A6 (0.51) CYP2A6ALDH1A1KDM4ERAB9APTGS2
SCHEMBL19462649 0.77 CYP2A6 (0.42) CYP2A6ALDH1A1TSHRKIF11KDM4E
SCHEMBL423281 0.74 CYP2A6 (0.64) CYP2A6ALDH1A1POLBMAPTCHRNA7
SCHEMBL17669447 0.73 FFAR1 (0.45) CYP2A6ALDH1A1ALDH1A3PTGS2
SCHEMBL17669319 0.73 FFAR1 (0.44) CYP2A6PTGS2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066371-A1 SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2015-05-07 WO disclosed
EP-1020427-B1 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2003-10-01 EP disclosed
EP-1223169-A1 Agent for potentiating nerve growth factor activity containg 1,2-ethanediol derivate or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2002-07-17 EP disclosed
EP-0790246-B1 POTENTIATOR FOR NERVE GROWTH FACTOR ACTIVITY CONTAINING 1,2-ETHANEDIOL DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2002-01-16 EP disclosed
US-6103754-A Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2000-08-15 US disclosed
EP-1020427-A1 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2000-07-19 EP disclosed
US-6034119-A Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2000-03-07 US disclosed
US-5968935-A ADMINISTERING TO TREAT NERVOUS SYSTEM DISORDERS TOYAMA CHEMICAL CO.., LTD. (JP) 1999-10-19 US disclosed
US-5932620-A Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 1999-08-03 US disclosed
US-5922721-A USE IN TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S CHOREA, AMYOTROPHIC LATERAL SCLEROSIS AND TRAUAMTIC NERVE INJURIES TOYAMA CHEMICAL CO., LTD. (JP) 1999-07-13 US disclosed
US-5807887-A COGNITION ACTIVATOR; ALZHEIMER*S, HUNTINGTON DISEASE TOYAMA CHEMICAL CO., LTD. (JP) 1998-09-15 US disclosed
EP-0790246-A1 POTENTIATOR FOR NERVE GROWTH FACTOR ACTIVITY CONTAINING 1,2-ETHANEDIOL DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 1997-08-20 EP disclosed